학술논문

One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study
Document Type
Article
Source
In Blood Advances 26 December 2023 7(24):7539-7550
Subject
Red Cells, Iron, and Erythropoiesis
Clinical Trials and Observations
Language
ISSN
2473-9529